NCT06222437 2026-03-23
Semaglutide and Polycystic Ovarian Syndrome: an Emerging Treatment Strategy
Methodist Health System
Phase 1 Withdrawn
Clinical Trials
6 trialsNCT07202247 2026-02-04
Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
City of Hope Medical Center
Phase 2 Recruiting
NCT05819853 2025-08-28
RESTORE
University of Colorado, Denver
Phase 3 Recruiting
NCT06908694 2025-07-29
GAINPCCONTROL
Hamilton Health Sciences Corporation
Phase 4 Recruiting
NCT06896981 2025-04-02
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Phase 2/3 Recruiting
NCT05702905 2024-03-25
Semaglutide Improves Metabolic Abnormalities and Fertility in Obese Infertile Women With Polycystic Ovary Syndrome
Peking University First Hospital
Phase 4 Unknown